Risk of serious neurologic disease after immunization of young children in Britain and Ireland

Pediatrics

Volumn 120, Issue 2, 2007, Pages 314-321

  Ward, Katherine N ^a   Bryant, Naomi J ^a   Andrews, Nick J ^b   Bowley, Jennifer S ^a   Ohrling, Anu ^a   Verity, Christopher M ^c   Ross, Euan M ^d   Miller, Elizabeth ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Encephalitis; Febrile convulsions; HHV 6 HHV 7; Status epilepticus; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; EPILEPTIC STATE; FEBRILE CONVULSION; HERPES SIMPLEX ENCEPHALITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; UNITED KINGDOM;

CHILD, PRESCHOOL; ENGLAND; HUMANS; INFANT; IRELAND; MEASLES VACCINE; MENINGOCOCCAL VACCINES; MUMPS VACCINE; NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; RISK FACTORS; RUBELLA VACCINE; VACCINATION;

EID: 34547654301     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3743     Document Type: Article

References (35)

1. Fenner F, Henderson DA, Arita I, et al. Smallpox and Its Eradication. Geneva, Switzerland: World Health Organization; 1988
2. Aylward RB, Sutter RW, Heymann DL. Policy. OPV cessation: the final step to a "polio-free" world. Science. 2005;310:625-626
3. Health Protection Agency. Protecting the health of England's children: the benefit of vaccines - first national report on the current status of the universal vaccine programmes from the Centre for Infections, 2005. Available at: www.hpa.org.uk/publications/PublicationDisplay.asp?PublicationID=8. Accessed June 6, 2007
4. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-226
5. Miller E, Salisbury D, Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine. 2002;20(suppl 1):S58-S67
6. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995; 345:567-569
7. Barlow WE, Davis RL, Glasser JW, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345:656-661
8. Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA. 2004;292:351-357
9. Ellenberg JH, Nelson KB. Febrile seizures and later intellectual performance. Arch Neurol. 1978;35:17-21
10. Verity CM, Greenwood R, Golding J. Long-term intellectual and behavioral outcomes of children with febrile convulsions. N Engl J Med. 1998;338:1723-1728
11. Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics. 1998;101:383-387
12. Miller E, Andrews N, Stowe J, et al. The risk of convulsions and aseptic meningitis after MMR vaccination in the UK. Am J Epidemiology. 2007;165:704-709
13. Alderslade R, Bellman MH, Rawson NSB, et al. The National Childhood Encephalopathy Study: A Report on 1000 Cases of Serious Neurological Disorders in Infants and Young Children From the NCES Research Team. Whooping Cough: Reports From the Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation. London, United Kingdom: Her Majesty's Stationery Office, 1981:79-169
14. Ward KN, Andrews NJ, Verity CM, Miller E, Ross EM. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child. 2005;90: 619-623
15. British Paediatric Surveillance Unit. 16th Annual Report. 2002. Available at: www.rcpch.ac.uk/Publications/Publications-list-by-title. Accessed June 6, 2007
16. Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at the Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis. 1998;26:398-409
17. Ward KN, Gray JJ, Fotheringham MW, Sheldon MJ. IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. J Med Virol. 1993;39:131-138
18. Ward KN, Turner DJ, Couto Parada X, Thiruchelvam AD. Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections. J Clin Microbiol. 2001;39:959-963
19. Ward KN, Couto Parada X, Passas J, Thiruchelvam AD. Evaluation of specificity and sensitivity of indirect immunofluorescence tests for IgG to human herpesviruses-6 and -7. J Virol Methods. 2002;106:107-113
20. Miller DL, Ross EM, Alderslade R, Bellman MH, Rawson NS. Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed). 1981;282:1595-1599
21. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(suppl 1):S4-S16
22. Miller E, Goldacre M, Pugh S, et al. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet. 1993;341(8851):979-982
23. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial In biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768-1797
24. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med. 1994;331:432-438
25. Caserta MT, Hall CB, Schnabel K, et al. Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr. 1998; 133:386-389
26. Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia. 1994;35(suppl 2):S1-S6
27. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592-596
28. Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics. 1978;61:720-727
29. Chin RFM, Neville BGR, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006; 368:222-229
30. Verity CM, Ross EM, Golding J. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. BMJ. 1993;307:225-228
31. Shinnar S, Pellock JM, Berg AT, et al. Short-term outcomes of children with febrile status epilepticus. Epilepsia. 2001;42: 47-53
32. Miller D, Wadsworth J, Diamond J, Ross E. Measles vaccination and neurological events. Lancet. 1997;349:730-731
33. Koskiniemi M, Vaheri A. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet. 1989; 1(8628):31-34
34. Makela A, Nuorti JP, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002;110: 957-963
35. Ray P, Hayward J, Michelson D, et al. Encephalopathy after whole-cell pertussis or measles vaccination. Lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J. 2006;25:768-733